The World Bladder Cancer Patient Coalition hosts this special month to highlight the facts about bladder cancer, promote awareness of the disease and call for more investment in research, treatment...
Updates on urinary biomarkers in urothelial carcinoma
Stay up to date with the latest developments in urinary biomarkers for bladder cancer and UTUC. Explore educational articles, scientific reviews, expert commentaries, and clinical cases covering emerging evidence and evolving approaches to detection and surveillance.
How to improve conventional cystoscopy for bladder cancer diagnosis and follow-up?
Watch the case presentation of Dr. Ekaterina Laukhtina (Moscow, Russia) At the 19th Meeting of the EAU Section of Oncological Urology (ESOU22), held on 21-23 January 2022 in Madrid, Spain, Dr....
Why urinary biomarkers should be used for the surveillance of non-muscle-invasive bladder cancer
Clinical case presentation by Dr. Ekaterina Laukhtina (Moscow, Russia) Editorial comment by Morgan RouprĂȘt The implementation and advantages of urinary biomarkers for non-muscle-invasive-bladder...
Compare your opinion with peers and Prof. Dr. Paolo Gontero
Jimmy is a 68-year-old retired kindergarten teacher. Whenever he can, he volunteers to read to children during story time at the local library. He was first diagnosed with low-grade...
The role of biomarkers in the diagnostic process of bladder carcinoma
Watch the presentation of Dr. Félix Guerrero Ramos (Madrid, Spain) The virtual 1st International Workshop in Urothelial Carcinoma took place on the 7th and 14th of October 2021 and was organized by...
Compare your opinion with peers and Dr. Joost Boormans
Cystoscopy* has a high sensitivity for detecting carcinoma in situ (CIS) in non-muscle-invasive bladder cancer (NMIBC). Therefore, it can accurately rule out this high-grade and aggressive tumour....






